Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...

The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by ...

The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products ...

The FDA on Thursday authorized the marketing of 20 ZYN nicotine pouches, including flavors, which UBS tells investors is a “slight positive” ...

The FDA approved nicotine pouches from ZYN, deeming them safer than cigarettes. Thursday’s decision allows ZYN to remain on ...

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

Federal health officials authorize Zyn nicotine pouches, citing potential to help adult smokers cut back or quit.

The agency found Zyn’s benefit as a safer alternative for adult cigarette smokers outweighs its risk to young people.

FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting ...

Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN ...

Morgan Stanley analyst Eric Serotta initiated coverage of Philip Morris (PM) with an Overweight rating and $140 price target The company is ...

A U.S. appeals court temporarily blocked a generic version of Novartis' Entresto, and new price limits challenge pharma as ...